期刊文献+

某综合性三甲医院1970例Ⅰ类切口预防使用抗菌药物分析 被引量:4

Analysis of Prophylactic Use of Antibiotics in 1970 Cases of Type Ⅰ Incision in a General Hospital with Grade 3A
下载PDF
导出
摘要 目的分析综合性医院Ⅰ类切口预防性使用抗菌药物的合理性。方法调查某综合性三甲医院2016年10月至12月1 970例Ⅰ类切口手术在围术期抗菌药物的使用,统计其使用率和合理率。结果 1 970例患者中,合理用药1 873例,合理率为95.08%;预防性使用抗菌药物304例,预防使用率为15.43%,其中不合理使用97例,无指征预防应用抗菌药物占14.53%,抗菌药物品种选择不当的占24.79%,给药时机不当的占2.56%,预防用药疗程超过24 h占58.12%。结论Ⅰ类切口手术预防使用抗菌药物的使用率达标,不合理使用的现象仍然存在,尤其是预防性用药疗程过长问题明显。Ⅰ类切口手术预防应用抗菌药物有待继续规范和提高。 Objective To analyze the rationality of prophylactic use of antibiotics in typeⅠincision in a general hospital. Methods The use of antibiotics in 1970 cases of typeⅠincision surgery in perioperative period from October to December in 2016 in a general hospital with grade 3A was investigated, and their utilization rate and reasonable rate were evaluated. Results In the 1970 cases of typeⅠincision surgery, 1873 cases of antimicrobial agents were reasonable, the reasonable rate was 95. 08%, there were 304 cases of prophylactic use of antibiotics, the prophylactic use rate was 15. 43%, In the 97 cases of irrational use of antibiotics, 14. 53% of them had no indications , 24. 79% of them were given improper selection of antibacterial drugs , 2. 56% of them were given improper administration, and 58. 12% of the courses of prophylactic medication were more than 24 h. Conclusion The use rate of prophylactic use of antibiotics in typeⅠincision surgery is up to standard, but the irrational use still exists, especially the long course of preventive medication is obvious. Prophylactic use of antibiotics in typeⅠincision surgery should be standardized and improved.
出处 《中国药业》 CAS 2017年第23期72-74,共3页 China Pharmaceuticals
关键词 综合医院 Ⅰ类切口手术 预防 抗菌药物 合理用药 general hospital typeⅠincision surgery prevention antibiotics rational drug use
  • 相关文献

参考文献4

二级参考文献27

  • 1杨红茹,齐顺祥,刘艳芳,刘兰芬,邸科前.人群甲型流感病毒M2蛋白变异与金刚烷胺耐药性分析[J].中国现代医学杂志,2008,18(23):3468-3471. 被引量:6
  • 2无.围手术期预防应用抗菌药物指南[J].中华外科杂志,2006,44(23):1594-1596. 被引量:843
  • 3钟晓祝,杨艳,舒承婷.围手术期抗菌药物预防应用前瞻性调查[J].中华医院感染学杂志,2007,17(3):317-319. 被引量:64
  • 4卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知[S].卫办医政发[2009]38号.2009.
  • 5WHO. Antimicrobial Resistance: Global Report on Surveillance 2014 [ R/OL]. [ 2014-115-05 ]. http://www, who. int/drugresis- tance/documents/surveillancereport/en/WHO. WHO Global Strategy for Containment of Antimicrobial.
  • 6Resistance[R/OL]. [2014-05- 05]. http://www, who. int/drugre- sistance/WH O_Global_St rat egy_English, pdf.
  • 7WHO. Combating Drug Resistance :No Action Today, No Cure Tomorrow [R/OL]. [ 2014-05-05 ]. http://www, who. int/ world-health-day/2011/en/.
  • 8Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumonia: a report of 2 cases and a brief review of the literature[J].Clin Infect Dis,2009,49(2):271-274.
  • 9Antibiotic Resistance Threats in The United States 2013[R/OL]. [2014-05-05 ]. http://www, cdc. gov/drugresistance/threat-re- port-2013/.
  • 10方芸.PDCA在医院临床药学管理中的应用[J].中国药房,2009,20(7):519-521. 被引量:58

共引文献68

同被引文献43

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部